Mechanism of Mycoplasma-Induced Mast Cell Il-4 Synthesis

支原体诱导肥大细胞 IL-4 合成的机制

基本信息

  • 批准号:
    7392363
  • 负责人:
  • 金额:
    $ 45.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2009-03-31
  • 项目状态:
    已结题

项目摘要

The overall goals of this project are to define innate and adaptive immune mechanisms by which Mycoplasma pneumoniae contributes to the development of chronic airway hyperreactivity and inflammation, focusing on the role of mast cells. Specific Aim 1: To clone and express the P1 adhesin of M. pneumoniae in E. coli and to produce a mutant M. pneumoniae strain deficient in that molecule. The P1 adhesin or select fragments involved in the mast cell IL-4 response will be cloned and expressed in E. coli. Using transposon mutagenesis, a P1-deficient strain of M. pneumoniae will be produced for use in mast cell stimulation experiments and the mouse model of infection. Specific Aim 2: To identify and characterize surface molecules on mast cells that are essential for induction of IL-4 production by P1 glycoprotein, examine modulating effects of other molecules in the pulmonary microenvironment, validate the effects observed using human mast cells, and characterize the effects of knockdown of expression of specific molecules involved in the M. pneumoniae cytokine response in mast cell lines. Target molecules for M. pneumoniae-induced mast cell cytokine production will be identified and characterized and the effects of mutational deletion examined, modulating effects of mediators in the pulmonary microenvironment will be analyzed, and effects of M. pneumoniae in a new human mast cell line will be studied. Specific Aim 3: To determine if respiratory tract infection by M. pneumoniae induces the recruitment to the airways of TH2 CD4 + lymphocytes, and to determine if this occurs using a mechanism that is dependent on mast cell-derived IL-4 or other mast cell products. The ability of M. pneumoniae to cooperate in the mast cell-induced recruitment of TH2 cells to the lungs and airways will be studied using adoptive transfer of antigen specific T cells. Specific Aim 4: To characterize the effects of infection in a mouse model under conditions in which interactions between M. pneumoniae and mast cells have been abrogated or in which mast cell IL-4 production is prevented. P1 deficient strain(s) of M. pneumoniae will be tested in mice for effects on airway hyperreactivity in a chronic infection model. The role of target molecules on the mast cells for M. pneumoniae-induced cytokine production will be studied in mutant strains of mice.
该项目的总体目标是确定肺炎支原体促进慢性气道高反应性和炎症发展的先天和适应性免疫机制,重点关注肥大细胞的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS PRESCOTT ATKINSON其他文献

THOMAS PRESCOTT ATKINSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS PRESCOTT ATKINSON', 18)}}的其他基金

Emerging Macrolide Resistance in Mycoplasma Pneumoniae
肺炎支原体中新出现的大环内酯类耐药性
  • 批准号:
    7712312
  • 财政年份:
    2009
  • 资助金额:
    $ 45.56万
  • 项目类别:
Emerging Macrolide Resistance in Mycoplasma Pneumoniae
肺炎支原体中新出现的大环内酯类耐药性
  • 批准号:
    7897731
  • 财政年份:
    2009
  • 资助金额:
    $ 45.56万
  • 项目类别:
Mechanism of Mycoplasma-Induced Mast Cell Il-4 Synthesis
支原体诱导肥大细胞 IL-4 合成的机制
  • 批准号:
    7063425
  • 财政年份:
    2005
  • 资助金额:
    $ 45.56万
  • 项目类别:
Mechanism of Mycoplasma-Induced Mast Cell Il-4 Synthesis
支原体诱导肥大细胞 IL-4 合成的机制
  • 批准号:
    6853461
  • 财政年份:
    2004
  • 资助金额:
    $ 45.56万
  • 项目类别:
ROLE OF MYCOPLASMA INFECTION IN CHILDHOOD ASTHMA
支原体感染在儿童哮喘中的作用
  • 批准号:
    6980481
  • 财政年份:
    2004
  • 资助金额:
    $ 45.56万
  • 项目类别:
MYCOPLASMA INFECTIONS AND CHILDHOOD ASTHMA
支原体感染和儿童哮喘
  • 批准号:
    2704670
  • 财政年份:
    1998
  • 资助金额:
    $ 45.56万
  • 项目类别:
MYCOPLASMA INFECTIONS AND CHILDHOOD ASTHMA
支原体感染和儿童哮喘
  • 批准号:
    6056549
  • 财政年份:
    1998
  • 资助金额:
    $ 45.56万
  • 项目类别:
MYCOPLASMA INFECTIONS AND CHILDHOOD ASTHMA
支原体感染和儿童哮喘
  • 批准号:
    6527184
  • 财政年份:
    1998
  • 资助金额:
    $ 45.56万
  • 项目类别:
MYCOPLASMA INFECTIONS AND CHILDHOOD ASTHMA
支原体感染和儿童哮喘
  • 批准号:
    6390052
  • 财政年份:
    1998
  • 资助金额:
    $ 45.56万
  • 项目类别:
MYCOPLASMA INFECTIONS AND CHILDHOOD ASTHMA
支原体感染和儿童哮喘
  • 批准号:
    6184720
  • 财政年份:
    1998
  • 资助金额:
    $ 45.56万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.56万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 45.56万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.56万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.56万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.56万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.56万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.56万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 45.56万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 45.56万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 45.56万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了